Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New heart test could reduce need for risky biopsies

NCT ID NCT06656065

First seen Nov 21, 2025 · Last updated May 24, 2026 · Updated 22 times

Summary

This study looks at a new way to check the health of tiny blood vessels in the heart after a transplant. Researchers will measure something called the index of microvascular resistance (IMR) in 100 heart transplant patients during their first year. The goal is to see if IMR can help doctors spot rejection early and possibly reduce the number of invasive heart biopsies needed.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART TRANSPLANT REJECTION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hospital Miguel Servet

    RECRUITING

    Zaragoza, Zaragoza, 50009, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

  • Hospital Universitario de Bellvitge

    ACTIVE_NOT_RECRUITING

    L'Hospitalet de Llobregat, Barcelona, 08907, Spain

Conditions

Explore the condition pages connected to this study.